Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by registry

Comparative statistics by cancer registry

Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site

(Busan, South Korea, 1996-2001 cases followed-up until 2003)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	Total included	Dead		Alive		Complete FU		Median FU (in months)
Site	ICD-10	Total included	No.	%	No.	%	No.	%	Median FU (in months)
C01-02	Tongue	144	74	51.4	70	48.6	144	100.0	28.5
C03-06	Oral cavity	156	91	58.3	65	41.7	156	100.0	31.3
C07-08	Salivary gland	86	26	30.2	60	69.8	86	100.0	39.7
C09	Tonsil	59	29	49.2	30	50.8	59	100.0	26.9
C10	Other oropharynx	34	29	85.3	5	14.7	34	100.0	12.5
C11	Nasopharynx	134	65	48.5	69	51.5	134	100.0	35.8
C12-13	Hypopharynx	87	71	81.6	16	18.4	87	100.0	12.6
C15	Oesophagus	790	660	83.5	130	16.5	790	100.0	8.7
C16	Stomach	8683	5063	58.3	3620	41.7	8683	100.0	25.4
C17	Small intestine	141	107	75.9	34	24.1	141	100.0	11.3
C18	Colon	1859	903	48.6	956	51.4	1859	100.0	32.5
C19-20	Rectum	1882	883	46.9	999	53.1	1882	100.0	34.7
C21	Anus	60	33	55.0	27	45.0	60	100.0	29.8
C22	Liver	6507	5811	89.3	696	10.7	6507	100.0	5.0
C23-24	Gall bladder	1524	1285	84.3	239	15.7	1524	100.0	7.0
C25	Pancreas	1011	950	94.0	61	6.0	1011	100.0	4.6
C30-31	Nose/Sinuses	103	71	68.9	32	31.1	103	100.0	22.3
C32	Larynx	475	234	49.3	241	50.7	475	100.0	37.6
C33-34	Lung	4796	4232	88.2	564	11.8	4796	100.0	6.9
C37-38	Other thoracic organs	148	98	66.2	50	33.8	148	100.0	18.3
C40-41	Bone	196	86	43.9	110	56.1	196	100.0	35.5
C43	Melanoma skin	86	52	60.5	34	39.5	86	100.0	29.1
C44	Other skin	423	102	24.1	321	75.9	423	100.0	50.6
C45	Mesothelioma	30	26	86.7	4	13.3	30	100.0	7.4
C47+C49	Connective tissue	250	137	54.8	113	45.2	250	100.0	31.8
C50	Breast	2642	510	19.3	2132	80.7	2642	100.0	47.8
C51	Vulva	25	8	32.0	17	68.0	25	100.0	40.9
C53	Cervix	2264	565	25.0	1699	75.0	2264	100.0	50.6
C54	Corpus uteri	265	60	22.6	205	77.4	265	100.0	45.3
C56	Ovary	622	268	43.1	354	56.9	622	100.0	34.9
C58	Placenta	30	4	13.3	26	86.7	30	100.0	57.1
C60	Penis	29	9	31.0	20	69.0	29	100.0	55.9
C61	Prostate	430	243	56.5	187	43.5	430	100.0	32.3
C62	Testis	55	13	23.6	42	76.4	55	100.0	53.4
C64	Kidney	706	296	41.9	410	58.1	706	100.0	35.3
C65	Renal pelvis	74	38	51.4	36	48.6	74	100.0	28.7
C66	Ureter	77	38	49.4	39	50.6	77	100.0	27.2
C67	Urinary bladder	999	385	38.5	614	61.5	999	100.0	37.1
C69	Eye	36	14	38.9	22	61.1	36	100.0	51.1
C70-72	Brain & nervous system	520	317	61.0	203	39.0	520	100.0	13.2
C73	Thyroid	1175	118	10.0	1057	90.0	1175	100.0	50.0
C74-75	Adrenal gland, other endocrine	56	26	46.4	30	53.6	56	100.0	28.4
C81	Hodgkin lymphoma	52	19	36.5	33	63.5	52	100.0	39.3
C82-85+C96	Non-Hodgkin lymphoma	785	443	56.4	342	43.6	785	100.0	25.8
C90	Multiple myeloma	182	155	85.2	27	14.8	182	100.0	12.3
C91	Lymphoid leukaemia	222	124	55.9	98	44.1	222	100.0	26.7
C92-94	Myeloid leukaemia	480	344	71.7	136	28.3	480	100.0	12.4
C95	Leukaemia unspecified	44	41	93.2	3	6.8	44	100.0	0.0

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Busan, South Korea, 1996-2001 cases followed-up until 2003)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Busan, South Korea, 1996-2001 cases followed-up until 2003)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Busan, South Korea, 1996-2001 cases followed-up until 2003)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Busan, South Korea, 1996-2001 cases followed-up until 2003)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)